N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
US7351725B2 · kind B2 · utility
17Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2003 |
| Grant date | Apr 1, 2008 |
| Priority date | — |
| Expiry date | May 29, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65586
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention encompasses compounds of Formula (I) as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.